Page last updated: 2024-08-17

ficusin and Cutaneous T-Cell Lymphoma

ficusin has been researched along with Cutaneous T-Cell Lymphoma in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's4 (50.00)29.6817
2010's0 (0.00)24.3611
2020's4 (50.00)2.80

Authors

AuthorsStudies
Ishii, T; Masuda, K; Mori, K; Nakahashi, K; Nihira, K; Suzuki, M1
Brandozzi, G; Bugatti, L; Campanati, A; Filosa, G; Giacchetti, A; Giantomassi, F; Goteri, G; Molinelli, E; Morsia, E; Mozzicafreddo, G; Offidani, AM; Olivieri, A; Rupoli, S; Serresi, S; Simonacci, M; Torre, E1
Heshmati, F1
Duvic, M; Morris, L; Reddy, S; Tran, J; Vu, A1
Bagot, M; Dreno, B; Dummer, R; Foss, F1
Ananthaswamy, HN; Bucana, C; Byrne, S; Matsumura, Y; Nghiem, DX; Ullrich, SE; Walterscheid, JP; Wolf, P1
Geskin, L1
Almagro, M; del Pozo, J; Fonseca, E; García-Silva, J; Martínez, W; Vázquez, J; Yebra-Pimentel, MT1

Reviews

1 review(s) available for ficusin and Cutaneous T-Cell Lymphoma

ArticleYear
ECP versus PUVA for the treatment of cutaneous T-cell lymphoma.
    Skin therapy letter, 2007, Volume: 12, Issue:5

    Topics: Ficusin; Humans; Lymphoma, T-Cell, Cutaneous; Photopheresis; Photosensitizing Agents; Skin Neoplasms; Treatment Outcome; Ultraviolet Therapy

2007

Other Studies

7 other study(ies) available for ficusin and Cutaneous T-Cell Lymphoma

ArticleYear
A novel mouse model of cutaneous T-cell lymphoma revealed the combined effect of mogamulizumab with psoralen and ultraviolet a therapy.
    Experimental dermatology, 2022, Volume: 31, Issue:11

    Topics: Animals; Ficusin; Lymphoma, T-Cell, Cutaneous; Methoxsalen; Mice; Mycosis Fungoides; PUVA Therapy; Skin Neoplasms; Ultraviolet Therapy

2022
Prognosis in early stage cutaneous T-cell lymphoma treated with psoralen plus ultraviolet A irradiation and low-dose interferon-α: Long-term efficacy and survival according to conventional and emerging clinical endpoints.
    Dermatologic therapy, 2022, Volume: 35, Issue:10

    Topics: Ficusin; Humans; Interferon-alpha; Lymphoma, T-Cell, Cutaneous; Mycosis Fungoides; Neoplasm Recurrence, Local; Prognosis; PUVA Therapy; Skin Neoplasms; Treatment Outcome

2022
[The past, present and future of extracorporeal photopheresis].
    Annales de dermatologie et de venereologie, 2020, Volume: 147, Issue:2

    Topics: Ficusin; History, 20th Century; History, Ancient; Humans; Immune Tolerance; Immunity, Cellular; Lymphoma, T-Cell, Cutaneous; Photopheresis; Photosensitizing Agents; Sezary Syndrome; Skin Neoplasms; T-Lymphocytes, Cytotoxic; T-Lymphocytes, Regulatory

2020
Anaphylaxis following administration of extracorporeal photopheresis for cutaneous T cell lymphoma.
    Dermatology online journal, 2020, Sep-15, Volume: 26, Issue:9

    Topics: Adult; Anaphylaxis; Anticoagulants; Disinfectants; Ethylene Oxide; Female; Ficusin; Glucocorticoids; Heparin; Histamine Antagonists; Humans; Lymphoma, T-Cell, Cutaneous; Photopheresis; Photosensitizing Agents; Skin Neoplasms

2020
Clinical experience: practical management of five patients with cutaneous T-cell lymphoma (CTCL)-related symptoms.
    Seminars in oncology, 2006, Volume: 33, Issue:1 Suppl 3

    Topics: Aged; Antineoplastic Agents; Carmustine; Combined Modality Therapy; Dermatitis, Exfoliative; Erythema Nodosum; Female; Ficusin; Humans; Lymphoma, T-Cell, Cutaneous; Male; Middle Aged; Mycosis Fungoides; Phototherapy; PUVA Therapy; Sezary Syndrome; Skin Neoplasms

2006
Platelet-activating factor is crucial in psoralen and ultraviolet A-induced immune suppression, inflammation, and apoptosis.
    The American journal of pathology, 2006, Volume: 169, Issue:3

    Topics: Animals; Apoptosis; Candida albicans; Candidiasis; Combined Modality Therapy; Female; Ficusin; Humans; Hypersensitivity, Delayed; Immune Tolerance; Immunosuppression Therapy; Inflammation; Interleukin-10; Lymphoma, T-Cell, Cutaneous; Male; Mice; Mice, Knockout; Platelet Activating Factor; Platelet Membrane Glycoproteins; Psoriasis; PUVA Therapy; Receptors, G-Protein-Coupled; Signal Transduction

2006
Cutaneous T-cell lymphoma presenting as disseminated, pigmented, purpura-like eruption.
    International journal of dermatology, 2001, Volume: 40, Issue:2

    Topics: Ficusin; Humans; Lymphoma, T-Cell, Cutaneous; Male; Middle Aged; PUVA Therapy; Skin; Skin Neoplasms

2001